Company Description
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source.
The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications.
Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
The company develops a prototype of the Nanox.ARC, a medical imaging system incorporating its digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that would allow for the delivery of medical screening as a service.
It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings.
The company was founded in 2011 and is headquartered in Neve Ilan, Israel.
Country | IL |
IPO Date | Aug 21, 2020 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 164 |
CEO | Erez I. Meltzer |
Contact Details
Address: Communications Center Neve Ilan, IL | |
Website | https://www.nanox.vision |
Stock Details
Ticker Symbol | NNOX |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001795251 |
CUSIP Number | M70700105 |
ISIN Number | IL0011681371 |
Employer ID | 00-0000000 |
SIC Code | 3844 |
Key Executives
Name | Position |
---|---|
Erez I. Meltzer | Chief Executive Officer & Acting Chairman of the Board |
Marina Gofman Feler | Chief Legal Officer |
Ran Daniel | Chief Financial Officer |
Tamar Aharon Cohen | Executive Vice President, Chief Marketing Officer and Head of the Sales & Marketing |
Dr. Orit Wimpfheimer M.D. | Chief Medical Officer & Vice President of Product Nanox AI |
Gali Yahav Attias | Chief of Corporate Resources |
James M. Dara | GM of Source & Services Division and Head of Nanox USA |
Noga Shabshin | Head of Tomosynthesis of ARC Division |
Ofir Koren | General Manager of Nanox.ARC Division |
Sharon Saban | Vice President of R&D and C.O.O. of AI Division |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 05, 2024 | 6-K | Filing |
Dec 03, 2024 | 6-K | Filing |
Nov 21, 2024 | 6-K | Filing |
Nov 08, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Oct 29, 2024 | 6-K | Filing |
Oct 24, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Sep 23, 2024 | 6-K | Filing |
Aug 20, 2024 | 6-K | Filing |
Jul 26, 2024 | 6-K | Filing |
Jun 26, 2024 | 6-K | Filing |